I mean, how do I see if two reads come from the same sample? The manual only tells me that 2 reads having identical QNAME are paired-end, right? Could someone tell how to read QNAME, above all it's such a long string of words that must tell something other than that...
-
-
I just wanted to know if there's barcode for sample information (in cases of pooled sample), where would it be? Thx~~ -
What manual?Comment
-
Often the QNAME is info about the instrument and the date of run, and the lane and tile and xy coordinates. The read group might tell you the sample name. That might be stored in an NM tag in the .sam file, or in the @RG header of the .sam fileComment
-
The NM tag is for the # of mismatches. Look in the RG header, if present.Originally posted by swbarnes2 View PostComment
-
-
Right, typo on my part. The SM tag might contain a sample name.Originally posted by nilshomer View PostComment
-
Well, the description for the SM tag is"SM:Sample. Use pool name where a pool is being sequenced." I wasn''t putting it clearly...what I meant was, if this sample is pooled, and the origins of the sample content each is barcoded, is it possible that this infomation is contained in .SAM format? And this must be contained in the non-header sectoin...Originally posted by swbarnes2 View Post
If it is not, how is that usually done? Is it customary that I ligate an adaptor to each sample origin, pool them, sequence, and look at the beginning of each read to see which origin of sample it came from?
Lots of thx!!!Comment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment